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Abstract
Background: Retinoids play an important role in skin homeostasis and when administered topically cause skin hyperplasia,
abnormal epidermal differentiation and inflammation. Thyroidal status in humans also influences skin morphology and
function and we have recently shown that the thyroid hormone receptors (TRs) are required for a normal proliferative
response to 12-O-tetradecanolyphorbol-13-acetate (TPA) in mice.
Methodology/Principal findings: We have compared the epidermal response of mice lacking the thyroid hormone receptor
binding isoforms TRa1 and TRb to retinoids and TPA. Reduced hyperplasia and a decreased number of proliferating cells in
the basal layer in response to 9-cis-RA and TPA were found in the epidermis of TR-deficient mice. Nuclear levels of proteins
important for cell proliferation were altered, and expression of keratins 5 and 6 was also reduced, concomitantly with the
decreased number of epidermal cell layers. In control mice the retinoid (but not TPA) induced parakeratosis and diminished
expression of keratin 10 and loricrin, markers of early and terminal epidermal differentiation, respectively. This reduction was
more accentuated in the TR deficient animals, whereas they did not present parakeratosis. Therefore, TRs modulate both the
proliferative response to retinoids and their inhibitory effects on skin differentiation. Reduced proliferation, which was
reversed upon thyroxine treatment, was also found in hypothyroid mice, demonstrating that thyroid hormone binding to
TRs is required for the normal response to retinoids. In addition, the mRNA levels of the pro-inflammatory cytokines TNFa
and IL-6 and the chemotactic proteins S1008A and S1008B were significantly elevated in the skin of TR knock-out mice after
TPA or 9-cis-RA treatment and immune cell infiltration was also enhanced.
Conclusions/significance: Since retinoids are commonly used for the treatment of skin disorders, these results
demonstrating that TRs regulate skin proliferation, differentiation and inflammation in response to these compounds
could have not only physiological but also therapeutic implications.
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Introduction
The skin, which protects organisms from the external
environment, is comprised of a stratified epithelium, the epidermis,
separated by a basement membrane from the underlying
connective tissue, the dermis. Skin homeostasis depends upon a
strict control of epidermal proliferation and differentiation.
Keratinocytes in the basal layer of the epidermis are able to
proliferate, differentiating as they move towards the skin surface
progressing through three layers, stratum spinosum, stratum
granulosum, and stratum corneum in which eventually cells
slough off the skin. Skin layers correspond to different differen-
tiation stages and they express specific markers: basal-layer
keratinocytes specifically express keratin (K) 5 and K14; spinous
cells express K1 and K10; and filaggrin, loricrin and transgluta-
minase 3 are produced in the granular layer [1].
Retinoids, the biologically active derivatives of vitamin A,
regulate important biological processes, such as development,
control and maintenance of homeostasis, cell growth, differenti-
ation and death [2]. Retinoids play an important role in skin
homeostasis and are widely used in cosmetics and in the treatment
of skin disorders [3]. In the skin, topical application of retinoic acid
(RA) generates epidermal hyperplasia that results from hyperpro-
liferation of basal keratinocytes leading, upon their vectorial
migration towards the skin surface, to thickening of the
differentiated suprabasal layers [3]. RA treatment also alters
epidermal cell differentiation causing parakeratosis [4] and
reducing expression of granular markers such as loricrin
[4,5,6,7,8,9], and causes skin irritation with infiltration of immune
cells [10,11]. Paradoxically, RA induces opposite responses in
keratinocytes depending on whether they are studied in vivo or
cultured in vitro, since RA treatment induces keratinocyte growth-
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23825arrest in vitro [12], while stimulating keratinocyte proliferation in
vivo.
Retinoids exert their action by binding to retinoic acid receptors
(RARa,- b, and –c), whose inactivation has a profound effect in
skin structure and function [13,14]. RARs regulate gene
expression by binding as heterodimers with other members of
the nuclear receptor superfamily, the retinoid-X-receptors (RXRa,
-b, and –c), to response elements located in the regulatory regions
of their target genes. However, retinoid receptors can modulate
gene expression through other mechanisms, including competition
of RARs with RXRs for binding to other heterodimerization
partners and transrepression of the activity of other transcription
factors [2,15,16]. RARs can be activated by all-trans retinoic acid
(all-trans-RA) and its stereoisomer, 9-cis retinoic acid (9-cis-RA),
whereas RXRs are only activated by 9-cis-RA. However, the
presence of 9-cis-RA as a true endogenous ligand, in the absence
of excessive retinoid intake, is questionable and some as of yet
unidentified ligand for RXR could be involved in its activity in
that tissue [17].
Similar to RA, the thyroid hormones exert their effects through
binding to nuclear receptors (TRa and TRb), which are known to
be expressed in the skin [18,19,20,21]. TRs interact with thyroid
hormone responsive elements (TREs), as heterodimers with RXRs
[22]. In hypothyroid humans the skin is cool and dry with a pasty
appearance, the epidermis is thin and hyperkeratotic, alopecia
may develop, and there is diffuse myxedema [23,24,25,26],
showing that thyroidal status influence skin morphology and
function. In addition, topical application of the thyroid hormone
triiodothyronine (T3) stimulates epidermal proliferation and
dermal thickening, in both mice and rats [27,28]. A TRa mutant
mice has been found to display retarded hair growth [29], and
using genetically modified mice we have recently observed that
effects of thyroid hormone on cell proliferation are mediated
through interactions with both TRa and TRb [30]. We found
reduced keratinocyte proliferation and decreased hyperplasia in
response to topical application of 12-O-tetradecanolyphorbal-13-
acetate (TPA), a well-known model for induction of skin
hyperproliferation and inflammation, in the epidermis of knock-
out mice lacking the thyroid hormone binding isoforms TRa1 and
TRb. Both receptor isoforms appear to play overlapping
functional roles, since mice lacking individually TRa1o rT R b
also present a proliferative defect but not as marked as that found
in double KO mice. Similar results were obtained in hypothyroid
animals, showing the important role of the liganded TRs on
epidermal proliferation. In addition, KO animals display aug-
mented expression of chemokines and proinflammatory cytokines,
demonstrating that TRs can also act as endogenous inhibitors of
skin inflammation[30].
In this work we have compared the epidermal response to
retinoids and the tumor promoter in hypothyroid and TR KO
mice. We found that liganded TRs are also required for a normal
response to retinoids. Skin hyperplasia, proliferation of keratino-
cytes and expression of keratins 5 and 6 are reduced in TR-
deficient mice treated with 9-cis-RA or TPA. As expected, the
retinoid caused parakeratosis and a decreased expression of
differentiation markers such as keratin 10 or loricrin, and these
responses were altered in the TR KO mice in which parakeratosis
was inhibited and expression of these markers was further reduced,
indicating that these receptors can play a role in both early and
terminal keratinocyte differentiation. Finally, increased levels of
transcripts coding for inflammatory cytokines and chemotactic
proteins were obtained in TR-deficient mice treated with either
TPA or 9-cis-RA, suggesting an increased inflammatory response.
This was further demonstrated by the finding that infiltration of
immune cells was increased in treated skins of TR KO mice.
Results
Reduced proliferative response to retinoids in mice
lacking thyroid hormone receptors
We have previously observed that the skin of knock-out mice
lacking TRa1 and TRb, the major TR isoforms that bind thyroid
hormones, shows reduced hyperplasia in response to topical
treatment with the tumor promoter TPA. To extend our
understanding on the role of TRs in skin proliferation, we
investigated the response of these mice to 9-cis-RA that also causes
epidermal proliferation [10]. As shown in Fig. 1A, the retinoid
caused a significant increase in skin thickness in wild-type and KO
mice, but KO animals displayed a reduced hyperplasia. As
expected, a reduced response to TPA stimulation was also found in
mice lacking TRs. To analyze if the reduced hyperplasia in these
animals is a consequence of reduced keratinocyte proliferation,
BrdU incorporation was examined in paraffin sections of 9-cis-RA
and TPA-treated skin incubated with an anti-BrdU antibody. As
shown in Fig. 2B, the BrdU labeling index increased significantly
after treatment with both compounds and this response was also
strongly reduced in KO mice. Fig. 1C shows representative images
of the histology and BrdU incorporation found in skins treated
with 9-cis-RA and TPA. It can be observed that although in wild-
type mice both agents caused hyperplasia and increased BrdU
incorporation, the retinoid (but not TPA) also produced
parakeratosis [31], characterized by the retention of nuclei in
the stratum corneum. Remarkably, in TR KO mice parakeratosis
was much less common and was only observed in isolated areas. In
addition, topical 9-cis-RA application caused the appearance of
skin wounds, which were more frequent in mice lacking the
receptors (data not shown).
To further analyze the role of TRs on the response to
retinoids, we compared the hyperplasia obtained after topical
application of 9-cis-RA and all-trans-RA in wild-type and KO
mice. As shown in Fig. 2, both retinoids induced a similar
increase in epidermal thickness and the response to both
compounds was reduced to a similar extent in the animals
lacking TRs. Since all-trans-RA does not bind RXR, these
results confirm the implication of RAR in the epidermal
hyperproliferative response.
To analyze the mechanisms by which a reduced proliferative
response to 9-cis-RA was found in TR KO mice, we measured by
western blot the levels of proteins important for skin proliferation
(Fig. 3). We have previously reported that induction of Cyclin D1
in response to TPA was strongly reduced in these animals [31],
and as illustrated in Fig. 3, 9-cis-RA caused a strong induction of
total and nuclear Cyclin D1 expression in wild-type but not in TR
KO mice. Moreover, the nuclear levels of the AP-1 components c-
Jun and c-Fos were significantly induced by the retinoid in normal
mice but not in TR deficient mice. In addition, we analyzed
expression of the cyclin kinase inhibitor (CKI) p21 and p19
arf.A s
shown in Fig. 3, the nuclear levels of p19
arf were significantly
higher in TR KO mice, and a less marked increase of p21 was also
observed. In contrast with the changes found in the nuclear levels
of these proteins, the changes observed in their total levels were
modest, indicating that TRs can participate in regulating their
cellular localization. The pattern of nuclear expression of the
analyzed proteins could account for the skin hypoplasia observed
in TR-deficient animals, since they play an important role in
keratinocyte proliferation [32,33].
TRs and Skin Response to Retinoids
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We have previously shown that the response to TPA was
similarly reduced in TR KO mice and in mice made hypothyroid
by treatment with anti-thyroidal drugs. We then compared the
response to 9-cis-RA in these animals. As shown in Fig. 4,
hypothyroidism reduced epidermal hyperplasia and BrdU incor-
poration in response to the retinoid to an extent similar to that
obtained in the mice lacking the receptors. Furthermore, the effect
of hypothyroidism on epidermal thickness and proliferation was
reversed when mice were treated with a physiological substitution
dose of the thyroid hormone thyroxine, demonstrating that the
observed effects are directly attributed to the thyroidal status and
not to unspecific actions of the anti-thyroidal drugs used.
Role of TRs in expression of epidermal markers
Keratins are used as epidermal markers due to their specific
localization in the diverse skin layers. In normal skin K5 is
expressed in the basal layer and in the hair follicle keratinocytes
[34]. In agreement with our previous observations [31], K5
detected by immunofluorescence showed a normal expression and
localization in vehicle-treated wild-type and KO mice. After 9-cis-
RA or TPA treatment K5 expression is expanded in both groups,
although the number of labeled keratinocyte layers was reduced in
Figure 1. Reduced skin proliferation after 9-cis-RA and TPA treatment in TR-deficient mice. A) Dorsal skins of wild-type mice (Wt) and
knock-out mice lacking TRa1 and TRb (KO), were treated topically with vehicle (acetone), 9-cis-RA or TPA. Morphometric analysis were performed to
determine epidermal thickness (left panel) and proliferation rate in the basal layer was quantitated and is represented as the percentage of positive
BrdU cells vs. total cells (right panel). Data are shown as mean values 6 SE, and asterisks denote statistically significant differences relative to Wt mice
(*, P,0.05; ***, P,0.001). B) The upper panels show representative H&E staining of 9-cis-RA and TPA treated mice. The magnification in wild-type
mice shows parakeratosis induced by 9-cis-RA, which was absent in KO mice. The lower panels show representative BrdU immunostaining in the
same groups.
doi:10.1371/journal.pone.0023825.g001
Figure 2. Reduced hyperplasia in response to retinoids in mice
lacking TRs. Epidermal thickness was measured in wild-type and TR-
deficient mice after topical treatment with all-trans-RA (ATRA) and 9-cis-
RA. Data are shown as mean values 6 SE, and ***(P,0.001) represents
statistically significant differences relative to Wt mice.
doi:10.1371/journal.pone.0023825.g002
TRs and Skin Response to Retinoids
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Since the reduced proliferation in the intestinal epithelial cells of
TRa-deficient mice has been related to changes in b-catenin [35],
we also analyzed the expression and distribution of this protein in
the skin. However, we did not find any significant change in b-
catenin expression and/or localization in the absence of TRs.
Under normal conditions K6 is only expressed in the
keratinocytes of the hair follicle both in wild-type and KO
animals. Topical application of 9-cis-RA extended K6 expression
to upper keratinocyte layers of interfollicular epidermis in control
mice and this increase was reduced in KO animals. TPA
treatment also expanded K6 expression and there was a slight
reduction of K6 in the more external keratinocyte layers (Fig. 6A).
On the other hand, K10 is present in the stratum spinosum and is
considered as an early differentiation marker of keratinocytes [36].
This keratin had also a normal distribution in vehicle-treated KO
mice. TPA application induced the expansion of cell layers
expressing K10 in the skins of both experimental groups in
agreement with the induced hyperplasia, although less markedly in
KOs. On the contrary, treatment with the retinoid reduced
expression of K10 in wild-type mice, showing a discontinuous
pattern with absence of labeling in some areas. This reduction was
stronger in the skin of TR KO mice, suggesting that TRs
deficiency accentuates the decrease in early differentiation of
keratinocytes caused by the retinoid (Fig. 6A). As it can be
observed in the magnifications shown in Fig. 6B, colocalization of
K6 and K10 revealed marked differences between both groups
and treatments. After TPA treatment, co-localization was found in
the more external layers of the interfollicular epidermis in the wild-
type mice, whereas in the KO mice co-localization was not
observed due to the low expression of K10 in those layers. After 9-
cis-RA treatment, and due to the reduction of K10 expression,
colocalization of K6 and K10 was rarely observed in both
experimental groups, being limited to small cellular groups in wild-
type animals or even to isolated cells in KOs.
Loricrin is used as a marker for terminal differentiation, since it
is expressed in the more external epidermal layer. This protein is
synthesized in the stratum granulosum and is included in the
cellular envelope of the keratinocytes in the stratum corneum
[8,37]. Loricrin expression and localization was normal in wild-
type and KO animals under normal conditions and after TPA
treatment (Fig. 7A). However, 9-cis-RA treatment reduced loricrin
expression [8], which as in the case of K10 presented a patched
discontinuous pattern. This reduction was again more prominent
in the animals lacking TR (Fig. 7A) and in some animals loricrin
expression disappeared in large areas (Fig. 7B). These results
suggest that in the absence of TRs both early and late keratinocyte
differentiation are further repressed upon retinoid treatment.
Figure 3. Altered expression of proliferation-related proteins
in the skin of TR-deficient mice after 9-cis-RA treatment. Total
and nuclear skin cell lysates from Wt and KO mice treated topically with
9-cis-RA were used for Western blotting with the indicated antibodies.
Actin and lamin B were used as a loading control for total and nuclear
extracts, respectively.
doi:10.1371/journal.pone.0023825.g003
Figure 4. Hypothyroid mice and TR-deficient mice present
similarly reduced proliferation in response to 9-cis-RA. Epider-
mal thickness (left panel) and BrdU incorporation (right panel) were
determined in TR KO mice, mice treated with MMI and perchlorate for 4
months (hT) and in a group of animals receiving the anti-thyroidal
drugs plus thyroxine (hT+T4).
doi:10.1371/journal.pone.0023825.g004
Figure 5. Expression of the proliferation marker keratin 5 is
reduced in TR KO mice in response to proliferative stimuli.
Examples of double immunofluorescence images of keratin 5 (K5, red)
and b-catenin (green) expression in dorsal skin of wild-type (Wt) and TR-
deficient mice (KO) after topical treatment with vehicle, 9-cis-RA or TPA.
The slides were counterstained with dapi (blue) and the merged images
are shown.
doi:10.1371/journal.pone.0023825.g005
TRs and Skin Response to Retinoids
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e23825Retinoid-induced inflammation is enhanced in the
absence of TRs
We have observed that the skin inflammatory response to TPA is
enhanced in TR KO mice, with an increase in the content of
chemical mediators and augmented infiltration of immune cells.
Since hyperproliferation in response to 9-cis-RA is also accompa-
niedby inflammatory cells infiltration [10,11], we measured mRNA
levels of the proinflammatory cytokines IL-6 and TNFa and the
chemotactic factors S100A8 and S100A9, in response to 9-cis-RA
and TPA in the skin of wild-type and TR KO mice. As shown in
Fig. 8, treatment with both compounds induced substantial
increases in the transcripts coding for these proteins, which play
pivotal roles in the recruitment of inflammatory cells, and this
induction was stronger in the animals lacking the receptors.
Immune cell infiltration in response to 9-cis-RA was analyzed
by immunofluorescence with specific cell markers (mac1 for
macrophages, cd45 for B and T lymphocytes and cd3e for T
lymphocytes). As shown in Fig. 9, immune cell infiltration was low
in vehicle-treated mice, but increased significantly after the topical
treatment with the retinoid, being more noticeable in the case of T
lymphocytes, in the TR KO animals. These results reinforce the
idea that TRs act as endogenous inhibitors of skin inflammation.
Discussion
We have previously shown that TRs are required to attain a
normal proliferative skin response to TPA, and our present results
indicate that the response to retinoids is also regulated by these
receptors. Retinoids are known to induce epidermal hyperplasia
and our results show that this response is blunted in genetically
modified mice lacking TRs. RA-induced skin hyperplasia most
probably involves RARc/RXRa heterodimers, in which RXR
transcriptional activity is subordinated to that of RAR, i.e.
liganded RXR is inactive unless its RAR partner is itself liganded
[38]. Our data are compatible with this hypothesis, since lack of
TRs affected both the response to 9-cis-RA and to the RAR-
specific ligand all-trans-RA. As cell proliferation only takes place in
the basal layer, the finding that RARc/RXRa heterodimers,
which are present in suprabasal keratinocytes, are required for
RA-induced epidermal hyperplasia demonstrates that retinoids
induce, through these heterodimers, the synthesis of a paracrine
signal in suprabasal keratinocytes, which in turn causes hyperpro-
liferation of basal keratinocytes [39,40]. Therefore, TRs could
modulate either the RA-induced signal or the response of the basal
layer keratinocytes to that signal. Our results showing that the
response to other hyperproliferative stimulus such as TPA, which
act through different signalling pathways, is also affected in TR
KO mice suggests that the second possibility is more likely. On the
other hand, deletion of TRs, which share the heterodimeric
partner with RARs, could favor formation of RXR homodimers,
RAR/RXR heterodimers, or even heterodimerization of RXR
with other nuclear receptors that could affect epidermal
proliferation [41,42]. However, the altered skin response to TPA
is most likely independent of these mechanisms. In addition, we
cannot dismiss the possibility that in the absence of TRs increased
availability of coactivators or corepressors could affect the response
to other nuclear receptors [43], or even other transcription factors
that associate with those coregulators affecting skin physiology.
Moreover, TR deficiency could also have indirect effects on the
regulation of the skin response to retinoids or TPA. It is well
known that thyroid hormones in mammalian cells affect basal
Figure 6. Keratin 6 and 10 expression in TR-deficient mice. A)
The proliferation marker keratin 6 (K6, red) and the early differentiation
marker keratin 10 (K10, green) were detected by immunofluorescence
in wild-type and TR KO mice before and after application of 9-cis-RA or
TPA. Nuclei were stained with dapi (blue). Panel B) represents a larger
magnification of the merged images shown in A) for a better
observation of K6 and K10 colocalization and the decrease in K10
expression observed in TR-deficient mice after 9-cis-RA treatment.
doi:10.1371/journal.pone.0023825.g006
Figure 7. TR deletion alters expression of loricrin. A) Localization
by immunofluorescence of the terminal differentiation marker loricrin in
the most external epidermal layer of skins from wild-type and TR KO
mice treated with 9-cis-RA and TPA. Loricrin expression (red)
demonstrates that 9-cis-RA (but not TPA) promotes altered differenti-
ation and that this is more marked in mice lacking TRs. Panel B) shows
that loricrin is totally absent in large areas of the skin of some TR KO
animals after 9-cis-RA treatment.
doi:10.1371/journal.pone.0023825.g007
TRs and Skin Response to Retinoids
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many other physiological processes that could regulate skin
homeostasis in an indirect manner. For example, hypoxia,
mitochondrial damage etc., could have similar effects as TR
deficiency, blunting the proliferative responses to retinoids or
TPA, while enhancing the proinflammatory responses evoked by
the damaged cells. However, at least part of the effects of TRs
appear to be exerted directly in the keratinocytes, since we have
found decreased proliferation and increased inflammatory medi-
ators in primary cultures of keratinocytes obtained from newborn
TR KO mice [30].
It has been previously observed that the phenotype of
hypothyroid mice is not identical to that of mice lacking TRs,
and that some alterations can be even less severe in the latter
[44,45,46], a difference that could be attributed to the effects of
the unliganded receptors that can act as constitutive repressors
[15,47]. This does not appear to be the case with skin
proliferation, since epidermal proliferation was similarly reduced
in hypothyroid and TR KO animals not only after retinoid
treatment, but also after application of TPA. Therefore, thyroid
hormone binding to the receptor appears to be required for a
normal proliferative response of epidermal keratinocytes. An
additional factor to consider is the possible participation of
thyrotropin (TSH) in the skin phenotype of hypothyroid and TR
KO mice. Both groups of animals present high circulating levels of
TSH and this hormone has been recently shown to influence skin
physiology [48,49]. However, the observation that topical
application of the thyroid hormones stimulates epidermal
proliferation in mice and rats [28,50], together with our results
obtained in primary keratinocytes favors the hypothesis of a direct
role of TRs on keratinocyte proliferation.
We have previously shown that the decreased proliferative
response of TR-deficient mice to TPA was accompanied by a
strong reduction in the induction of Cyclin D1 [30], and we now
Figure 8. Increased expression of proinflammatory and chemotactic molecules in skins of TR KO mice. Relative mRNA levels of TNFa, IL-
6, S100A8 and S100A9 in wild-type and TR KO mice treated with vehicle, 9-cis-RA or TPA. Values representing expression levels of vehicle-treated wil-
type mice were set to 1, and fold induction is represented relative to this basal level.
doi:10.1371/journal.pone.0023825.g008
Figure 9. Immune cell infiltration is enhanced in skins of TR deficient mice treated with 9-cis-RA. Double immunofluorescence images of
keratin 5 (K5) with mac-1 (left panel), cd45 (middle panel) and cd3e (right panel) in skins from wild-type and TR KO mice treated with 9-cis-RA or
vehicle alone. Nuclei were stained with dapi.
doi:10.1371/journal.pone.0023825.g009
TRs and Skin Response to Retinoids
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retinoid application in these animals. Since Cyclin D1 is a key
protein for keratinocyte proliferation [32], this reduction could
play an important role in the observed phenotype. Furthermore,
we confirmed a strong increase in the levels of the p19
arf in the skin
nuclei of the TR KO mice, and we found lower levels of the AP-1
components c-Fos and c-Jun after retinoid treatment in these
animals. These changes are also compatible with the reduced
hyperplasia observed in TR-deficient animals. Interestingly,
whereas the nuclear levels of c-Fos and c-Jun are reduced after
retinoids administration in mice lacking TRs, these proteins were
higher in these animals than in wild-type animals after TPA
treatment [30], indicating again that different pathways underlie
the proliferative defect found after TPA and 9-cis-RA treatments.
It has been reported that TRs can regulate either positively or
negatively the expression of selected keratins in cultured cells.
Whereas the thyroid hormone stimulates K15 promoter activity in
transient transfection assays [51], K5 and K6 promoter activity is
enhanced by unliganded TR and the hormone reverses this
activation. This regulation appears to be mediated by a negative
TRE located relatively close to the TATA box that can also
mediate regulation by RA [52,53,54]. Our in vivo results indicate
that the reduced epidermal proliferation after retinoid or TPA
application was also evident by the changes in the expression of
K5 and K6 in TR deficient mice. Although distribution of K5 was
normal, a clear reduction in the number of cell layers expressing
this marker was observed after treatment in these animals. With
respect to K6, TPA treatment expanded K6 expression to
suprabasal layers of the interfollicular epidermis, both in the
presence and absence of TRs, as corresponding to a hyperproli-
ferative state [55,56]. However, reduced expression of K6 in the
most external layers was observed after TPA treatment in the
animals lacking TRs, a finding even more patent after treatment
with 9-cis-RA. Although this reduction can be linked to the
decreased epidermal proliferation in these animals, it has been
described that K6 expression is regulated by thyroid hormones in
cultured cells [41], and therefore a direct effect of TRs on this
reduction cannot be discarded. Furthermore, the decreased K6
expression could be related to the reduced epidermal proliferation
in TR KO mice since this keratin is known to increase epidermal
growth factor receptors signaling pathways [57].
Expression of the early (K10) and late (loricrin) differentiation
markers was not altered under basal conditions in the absence of
TRs and TPA treatment did not interfere with epidermal
differentiation. In normal animals 9-cis-RA treatment caused
parakeratosis, an abnormal keratinization of cells associated with
the thinning or loss of the granular layer, whereas this condition
was rarely observed in the KO mice suggesting that differentiation
could be altered in the absence of TRs. We observed that 9-cis-RA
treatment reduced expression of K10 and loricrin in normal and
TR deficient mice, in agreement with previous results demon-
strating that retinoids impair induction of differentiation markers
in cultured keratinocytes [6,56] and after topical treatment in vivo
[9]. However, this decrease was notably accentuated in the
animals lacking TRs. These results demonstrate that TRs act as
endogenous inhibitors of the actions of retinoid receptors in
epidermal differentiation and indicate that although in the absence
of TRs skin differentiation can occur normally under ordinary
conditions, these receptors are required to limit the deleterious
effects of retinoids on inhibiting differentiation of the epidermis.
In parallel with the hyperproliferative response, both TPA and
9-cis-RA provoke a strong inflammatory reaction
[10,11,58,59,60]. We have previously observed that in the skin
of TR KO mice this reaction is exacerbated after TPA treatment,
with activation of p65/NF-kB and Stat3 phosphorylation,
augmented expression of chemokines and pro-inflammatory
cytokines and increased dermal infiltration of immune cells [30].
An excessive inflammatory response was also observed in TRs
deficient mice after 9-cis-RA treatment. mRNAs for the pro-
inflammatory cytokines Il-6 and TNFa were more strongly
induced in the TR KO mice, and the same occurred with the
transcripts for the neutrophil recruiting proteins S100A8 and
S100A9, which are also believed to play an important role in the
pathogenesis of epidermal disease and inflammation [61]. The
ability of several members of the nuclear receptor superfamily to
attenuate inflammatory responses by transrepressing activation of
inflammatory response genes is well known. This transrepression
occurs by protein-protein interactions of the receptors with
coregulatory proteins and promoter-bound transcription factors,
rather than by direct, sequence-specific interactions with DNA
[62]. Our results reinforce the idea that thyroid receptors can also
act as endogenous controllers of inflammation, at least in the skin,
limiting immune responses to various pro-inflammatory stimuli
through repression of cytokines and chemotactic proteins.
In summary, our present results increase the knowledge of the
role of TRs and thyroid hormones in the skin. The liganded TRs
are required for a normal response of keratinocytes to retinoid-
induced proliferation and can also modulate keratinocytes
differentiation increasing the ability of these compounds to block
both early and terminal differentiation. Due to the relevant role of
retinoids in skin physiological and their wide therapeutic effects,
modulation of the responses to these agents by the thyroid
hormone receptors could have important functional implications.
Materials and Methods
Animals and Treatments
All animal work was done in compliance with the European
Community Law (86/609/EEC) and the Spanish law (R.D. 1201/
2005), with approval of the Ethics Committee of the Consejo
Superior de Investigaciones Cientı ´ficas. Experiments were per-
formed in adult female mice. TRa1
2/2/TRb
2/2 double
knockout (KO) mice and wild-type (TRa1
+/+/TRb
+/+) animals
with the same background [63] were genotyped and used for the
studies. Double KO males were crossed with heterocygote females,
and back-crosses were performed to avoid genetic drift. Wild-type
mice were made hypothyroid (hT) by treatment with 0.02%
methymazole and 0.1% sodium perchlorate in the drinking water
[20,30]. Treatment started when animals were 1 month old and
was continued for 4 months. This treatment reduced serum levels
of T4 measured with an ECL-based kit (Diagnostic Products Corp.
Los Angeles, CA) by approximately 80%. Starting one week after
treatment with the anti-thyroidal drugs, a group of mice received
daily a physiological dose of thyroxine (T4, 20 ng/g body weight)
(hT+T4). Dorsal skins were shaved and treated with depilatory
cream 24 h before the treatments with retinoids or TPA. The
retinoids 9-cis-RA and all-trans-RA (15 mg/mouse) were applied
topically once a day for 4 days and mice were killed 24 h after the
last application. TPA was applied twice (at days 2 and 4) and
animals were sacrificed at day 5. In the control group, animals
were treated with vehicle (acetone) only. At the end of the
experiments, skin was excised and either frozen to obtain RNA or
proteins, or fixed with 4% paraformaldehyde or 70% ethanol and
embedded in paraffin. Between 4 and 6 animals/experimental
group were used in each experiment. Skin sections were stained
with hematoxilin and eosin (H&E) or processed for immunohis-
tochemistry or immunofluorescence. For frozen sections (5 mm),
TRs and Skin Response to Retinoids
PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e23825fresh skin samples were embedded in OCT (TissueTech) and kept
frozen (280uC) until use.
Morphometric Analysis
Quantitation of the epidermal thickness was performed in dorsal
skin sections stained with H&E. At least 10 individual fields of
1 mm per slide from five mice of each experimental group were
counted using the software MetaMorph (Premier Offline 7.0;
Molecular Devices, Downingtown, PA).
BrdU Labeling
Epidermal proliferation was determined after ip injection of
bromodeoxyuridine (BrdU; 0.1 mg/g weight), 1 h prior sacrifice.
BrdU incorporation was detected by immunohistochemistry using
standard protocols on deparaffinized sections. Immunohistochem-
istry was performed with mouse anti-BrdU monoclonal antibody
(Roche, no. 1170376) as previously described, and the percentage
of BrdU-positive per total basal keratinocytes was calculated
[30,64].
Immunofluorescence
Epidermal differentiation was analyzed by indirect immunoflu-
orescence in frozen sections of skin as previously described [65,66].
Rabbit polyclonal antibodies antibodies against K5, K6, and
loricrin were obtained from Covance (Princeton, New Jersey
08540, USA), and used at 1:500 or 1:1000 dilutions. Keratin K10
was detected using a monoclonal antibody (Sta Cruz Biotechnol-
ogy, Santa Cruz, CA) at a 1:100 dilution. Immunodetection of
dermal inflammatory cells including T lymphocytes (anti-CD3e),
T and B lymphocytes (anti-CD45), and macrophages (anti-
CD11b/Mac1) was performed using fluorescein isothiocyanate-
labeled specific rat anti-mouse monoclonal antibodies (BD
Pharmigen, 10975 Torreyana Road, San Diego, CA 92121) at
1:50 dilution. Secondary antibodies were obtained from Jackson
ImmunoResearch Laboratories, Inc. (Suffolk, England) and were
used as previously described [66].
Western blot
Whole-cell and nuclear extracts [30] were isolated from the skin
of wild-type and TR KO mice treated with acetone or 9-cis-RA.
Samples from 4 individual animals in each group were pooled, and
50 mg of proteins were subjected to polyacrylamide gel electro-
phoresis, transferred to nitrocellulose membranes and used for
western blot as previously described [30]. Antibodies to Cyclin D1
(sc- 718), c-Jun (sc-1694), c-Fos (sc-52), lamin B (sc-6217), and
actin (sc-1616) were obtained from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA), and antibodies against p19
arf (Ab-7960) and
p21 (Ab-80) were purchased from Abcam Inc. (Cambridge, UK).
Quantitative real-time PCR assays
Total RNA was extracted from skin using RNeasy Fibrous Tissues
Mini Kit (Qiagen Iberia S.L, Las Matas, Spain) and mRNA levels were
analyzedintriplicatesamples byquantitativeRT-Q-PCRas previously
described [30], following specifications of SuperScript
TM First-Strand
Synthesis System (Invitrogen Life Technologies Carlsbad, California
92008, USA). The primers for used were: 59-GAACTGGCAGAA-
GAGGCACT -39 (forward) and 59-AGGGTCTGGGCCATAGA-
ACT-39 (reverse) for TNFa;5 9-AGTTGCCTTCTTGGGACTG-39
(forward) and 59-CAGAATTGCCATTGCACAA-39 (reverse) for IL-
6; 59-GGAATCACCATGCCCTCTA-39 (forward) and 59-TGGC-
TGTCTTTGTGAG ATGC-39 for S100A8 and 59-TCATCGA-
CACCTTCCATCAA-39 (forward) and 59-GTCCTGGTTTGTGT-
CCAGGT-39 (reverse) for S100A9. Data analysis was done using the
comparative CT method and data were corrected with the GPDH
mRNA levels estimated with primers 59-ACACTGCATGCCAT-
CACTGCC-39 (forward) and 59-GCCTGCTTCACCACCTTCT-
TG-39 (reverse).
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